Enovis to acquire implant maker LimaCorporate for 800 million euros in cash and stock
Medical technology company Enovis Corp. (ENOV) said Monday it has reached an agreement to acquire LimaCorporate S.p.A., a privately held orthopedic company that specializes in restoring motion using implants, for 700 million euros ($745 million) in cash at closing and another EUR100 million in Enovis stock. The deal is expected to create a $1 billion revenue reconstruction business with about half of that stemming from the fast-growing extremities business. The deal will add a portfolio of surgical technologies, including 3-D printed trabecular titanium, a lightweight biomaterial. Enovis is expecting Lima to generate sales of $290 million to $300 million in 2024 and to close early in the year. Enovis is sticking with its full-year guidance of organic sales growth of 7% to 7.5% for 2023, as well as adjusted per-share earnings of $2.22 to $2.36. The deal is expected to be neutral to slightly accretive to 2024 adjusted EPS and accretive in 2025 and beyond. The deal will be financed with a mix of cash in hand and an existing revolving credit facility, as well as committed financing from UBS and JPMorgan. Enovis shares are down 3.5% in the year to date, while the S&P 500 has gained 12.5%.
-Ciara Linnane
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-25-23 0614ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
These Stocks Are (Still) Powering the Bull Market
-
5 Undervalued Energy Stocks to Play the AI Data Center Demand Boom
-
After Earnings, Is Lowe’s Stock a Buy, Sell, or Fairly Valued?
-
5 Stocks With the Largest Fair Value Estimate Cuts After Q1 Earnings
-
10 Stocks With the Largest Fair Value Estimate Increases After Q1 Earnings
-
Markets Brief: Inflation Back in the Spotlight
-
AI Is Booming, but Consumer Spending Is Slowing. Which Will Prevail in the Stock Market?
-
What’s Happening In the Markets This Week
-
3 Dividend Stocks for June 2024
-
After Earnings, Is Alibaba Stock a Buy, Sell, or Fairly Valued?
-
MongoDB Earnings: Slashing Valuation as Execution and Macro to Blame for Lower Guidance
-
Marvell Earnings: We Raise Our Medium-Term AI Forecast and Bring Our Valuation Up to $75
-
Zscaler Earnings: Impressive Traction in Emerging Products Drives Sales Growth for the Quarter
-
Dell Earnings: Raising Valuation on Strong AI, but the Stock Remains Severely Overvalued
-
After Earnings, Is Nvidia Stock a Buy, Sell, or Fairly Valued?
-
The 10 Best Companies to Invest in Now